Immuron Ltd
For the period ended Oct 16, 2026. Filed Oct 16, 2026.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Oct 16, 2026 · Filed Oct 16, 2026
Use the contents to explore the available documents and sections.
IMRN$0.83-2.2%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · Finance Projects Implementation & Process Improvements Consultant
Finance Projects Implementation & Process Improvements Consultant
Retained to architect financial structures, global business processes, and commercial models during crucial product launches and preparation for international expansion.
| ● | Capital & Grant Procurement: Formulated a 10-year corporate plan, comprehensive business case, and commercialisation dossier that directly supported a US$125m capital raising and an A$100m Medical Research Future Fund (MRFF) grant. |
| ● | Global Commercialisation Partnering: Acted as the core finance business partner to US Sales and Global Marketing teams, steering the financial framework for the international soft launch of the EVOKE system. |
| ● | Listing Preparation & Systems Architecture: Reviewed global business processes ahead of a proposed NASDAQ listing; successfully deployed global payroll, procurement, asset management, and Workday Adaptive systems. |
| ● | International Tax Governance: Managed initial cross-border corporate registrations and drove the compliant lodgement of US Federal and State corporate tax returns. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.